Related Experiment Videos
Drug induced diabetes mellitus
1MV Diabetes Specialities Centre and Madras Diabetes Research Foundation, 44, Royapettah High Road, Chennai-600 014, India.
The Journal of the Association of Physicians of India
|March 7, 2001
Summary
Drug-induced diabetes is uncommon, suggesting underlying risks. Sulphonylureas are ineffective; insulin therapy is best. Thiazolidinediones may help with insulin resistance.
Area of Science:
- Endocrinology
- Pharmacology
Background:
- Drug-induced diabetes mellitus is a recognized adverse effect of various medications.
- The incidence appears low, suggesting predisposing factors may be involved.
- Elderly patients receiving multiple prescriptions are a vulnerable population.
Purpose of the Study:
- To explore the mechanisms and risk factors associated with drug-induced diabetes.
- To evaluate the efficacy of different therapeutic approaches for managing drug-induced diabetes.
Main Methods:
- Review of existing literature on drug-induced diabetes.
- Analysis of drug classes implicated in glucose dysregulation.
- Discussion of treatment strategies based on underlying mechanisms.
Main Results:
- Certain drugs can induce hyperglycemia through diverse mechanisms.
- Underlying metabolic abnormalities likely increase susceptibility.
- Sulphonylureas are generally ineffective for drug-induced diabetes.
- Insulin therapy is the preferred treatment when the offending drug must continue.
- Thiazolidinediones show promise for drug-induced diabetes linked to insulin resistance.
Conclusions:
- Drug-induced diabetes requires careful consideration of patient susceptibility.
- Treatment should be tailored to the specific drug and underlying pathophysiology.
- Further research into risk stratification and novel therapeutic agents is warranted.